Decoy Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCOY and other ETFs, options, and stocks.About DCOY
Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs.
CEOFrederick E. Pierce
CEOFrederick E. Pierce
Employees2
Employees2
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2020
Founded2020
Employees2
Employees2
DCOY Key Statistics
Market cap4.10M
Market cap4.10M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume120.68K
Average volume120.68K
High today$0.6399
High today$0.6399
Low today$0.5319
Low today$0.5319
Open price$0.54
Open price$0.54
Volume166.36K
Volume166.36K
52 Week high$34.65
52 Week high$34.65
52 Week low$0.5148
52 Week low$0.5148
Stock Snapshot
With a market cap of 4.1M, Decoy Therapeutics(DCOY) trades at $0.59. The stock has a price-to-earnings ratio of -0.02.
During the trading session on 2026-03-07, Decoy Therapeutics(DCOY) shares reached a daily high of $0.64 and a low of $0.53. At a current price of $0.59, the stock is +11.0% higher than the low and still -7.8% under the high.
Trading activity shows a volume of 166.36K, compared to an average daily volume of 120.68K.
Over the past 52 weeks, Decoy Therapeutics(DCOY) stock has traded between a high of $34.65 and a low of $0.51.
Over the past 52 weeks, Decoy Therapeutics(DCOY) stock has traded between a high of $34.65 and a low of $0.51.
People also own
Based on the portfolios of people who own DCOY. This list is generated using Robinhood data, and it’s not a recommendation.